Research groups
Colleges
Daniel C Anthony
Professor of Experimental Neuropathology
- Fellow of Somerville College
- Honorary Professor, University of Southern Denmark
- Fellow of the British Pharmacological Society
Daniel Anthony, a specialist in inflammatory disease, leads the Experimental Neuropathology Laboratory at the University of Oxford. As a Fellow of Somerville College and an Honorary Professor at the University of Southern Denmark, he has developed a niche in understanding how systemic inflammation influences the outcomes of both acute and chronic brain injuries and infections. His research interests also focus on the role of circulating extracellular vesicles in the pathogenesis of CNS diseases and the contribution of cytokine production to neuropsychiatric disorders.
Professor Anthony's career began with a Ph.D. from University College London in 1994, after which he joined Professor Hugh Perry in Oxford on a British Biotech Fellowship to explore metalloproteinase expression in the CNS. His work has led to the identification of novel biomarkers for diagnosing disease and predicting progression, leveraging a combination of in vivo biology, molecular biology, immunohistochemistry, MRI and PET imaging, and metabolomics. After a stint at the University of Southampton, where he was a Lecturer in Neurobiology, he returned to Oxford in 2004, where he continues to explore the neurobiology of inflammation with research collaborations throughout the world. In 2015, he was awarded a personal Chair in Experimental Neuropathology, and he was made a Fellow of the British Pharmacological Society in 2020.
Recent publications
Layer-Specific Astrocyte Morphological Responses in the CA3 Hippocampus Region During Piry Virus-Induced Encephalitis.
Journal article
de Almeida Miranda D. et al, (2026), Hippocampus, 36
Serum GFAP and NfL augment a metabolomics-driven strategy for long-term prediction of multiple sclerosis progression.
Journal article
Kacerova T. et al, (2026), Commun Med (Lond), 6
Integrating NMR Metabolomics and Glycomics for Early Cancer Detection in Patients with Non-Specific Symptoms
Preprint
Kacerova T. et al, (2026)
Lesion level and severity acutely influence metabolomic profiles in spinal cord injury.
Journal article
Yates AG. et al, (2026), J Neuropathol Exp Neurol, 85, 24 - 38
From fragmentation to integration: can social prescribing bridge the gap between multimorbidity and mental health in an ageing population?
Journal article
Radford-Smith DE. and Anthony DC., (2026), BMJ Public Health, 4
